Physician profile
Steven Sterious
NPI 1437318011
$71,582.59
in general payments reported to CMS, 2019-2025
24 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $15K · 2021: $11K · 2022: $13K · 2023: $320 · 2024: $314 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $69,939.68 | 2019-2022 | |
| Coloplast Corp | $302.76 | 2019-2024 | Speedicath |
| Dentsply Ih Ab | $286.70 | 2024-2025 | Lofric |
| Astellas Pharma US INC | $166.04 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $129.21 | 2023-2025 | Gemtesa |
| Ambu INC. | $117.03 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $87.15 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $84.50 | 2021-2023 | |
| Civco Medical Instruments | $51.31 | 2025 | |
| Alnylam Pharmaceuticals INC. | $48.57 | 2023-2024 | Oxlumo |
| Boston Scientific Corporation | $47.61 | 2020-2021 | |
| Convatec INC. | $38.34 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $34.63 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.63 | 2019 | |
| Olympus America INC. | $29.24 | 2025 | Itind System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $27.21 | 2023 | Erleada |
| Allergan, INC. | $26.79 | 2019 | |
| Teleflex LLC | $24.71 | 2023 | Urolift |
| Azurity Pharmaceuticals, INC. | $22.61 | 2025 | Azmiro |
| Avadel Specialty Pharmaceuticals, LLC | $22.37 | 2019 | |
| Acerus Pharmaceuticals Corporation | $19.73 | 2021 | |
| Progenics Pharmaceuticals, INC. | $17.45 | 2023 | Pylarify |
| Ethicon US, LLC | $14.57 | 2019 | |
| Baxter Healthcare | $13.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sterious listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.